4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-24-005161
Options or other derivatives
- Director acquired 23,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Dier Mardi Director | 2024-06-14 | Grant or award · Director Stock Option (Right to Buy) | +23,500 | 23,500 | D | ||
Loading xslF345X05/primarydocument.xml…